Verified Nov 2026
Batteries & E-Mobility
·
Oslo, Oslo
·
Since 1993
Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.
Photocure at a glance
Revenue
$50-100M
Est. band
Employees
100-200
Founded
1993
Headquarters
Oslo, Oslo
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.
At a glance
Attribute | Detail |
|---|---|
Founded | 1993 |
Headquarters | Oslo, Oslo |
Employees | 100-200 |
Revenue | $50-100M (estimated) |
Primary capability | Batteries & E-Mobility |
What Photocure makes
Photocure manufactures and commercializes photodynamic diagnostic and therapeutic products including Hexvix and Cysview for blue light cystoscopy detection of bladder cancer, with pipeline product Cevira targeting HPV infections and precancerous cervical lesions.
Latest developments
2026-11-09 — Photocure Provides Update on AssureMDx and Anticipated Medicare Coverage Timeline (photocure.com)
2026-10-28 — Photocure ASA: Results for the third quarter of 2026 - Photocure (cision.com)
2026-07-29 — Photocure ASA: Results for the second quarter of 2026 (photocure.com)
2026-06-04 — Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics (photocure.com)
2026-06-04 — Photocure to Acquire Vesica Health for $30.5M | GenomeWeb (genomeweb.com)
2026-05-07 — Photocure ASA: Results for the first quarter of 2026 (photocure.com)
Facilities
Photocure is headquartered in Oslo, Oslo. Public sources also reference these locations:
Oslo, Norway — photocure.com
Company details
The company operates commercial teams across North America and Europe and is publicly traded on the Oslo Stock Exchange under ticker PHO. Photocure was founded in 1993, has an estimated 100-200 employees, and is headquartered in Oslo, Oslo.
Frequently asked questions
What does Photocure make?
Photocure is a Norwegian specialty pharmaceutical company founded in 1993 and headquartered in Oslo. It employs 100–200 people and generates estimated revenue of $50–100 million annually. The company develops photodynamic diagnostic and therapeutic products for uro-oncology, bladder cancer, and cervical lesions, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. In June 2026, Photocure acquired Vesica Health for $30.5 million to strengthen its bladder cancer diagnostics portfolio.
Where is Photocure headquartered?
Photocure is headquartered in Oslo, Oslo (4 Hoffsveien, Oslo, Oslo, 0275).
When was Photocure founded?
Photocure was founded in 1993.
How big is Photocure?
Photocure has an estimated 100-200 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
